Abstract
Chronic spontaneous urticaria (CSU) is defined as the occurrence of spontaneous wheals, angioedema, or both for >6 weeks in the absence of specific causes. It is a common condition associated with substantial disease burden both for affected individuals and societies in many countries, including Korea. CSU frequently persists for several years and requires high-intensity treatment; therefore, patients experience deteriorations in quality of life and medication-associated complications. During the last decade, there have been major advances in the pharmacological treatment of CSU and there is an outstanding need for evidence-based guidelines that reflect clinical practice in Korea. The guidelines reported here represent a joint initiative of the Korean Academy of Asthma, Allergy and Clinical Immunology and the Korean Dermatological Association, and aim to provide evidence-based guidance for the management of CSU in Korean adults and children. In Part 1, disease definition, guideline scope and development methodology as well as evidence-based recommendations on the use of antihistamines and corticosteroids are summarized.
Original language | English |
---|---|
Pages (from-to) | 563-578 |
Number of pages | 16 |
Journal | Allergy, Asthma and Immunology Research |
Volume | 12 |
Issue number | 4 |
DOIs | |
State | Published - Jul 2020 |
Bibliographical note
Publisher Copyright:© 2020 Korean Academy of Asthma, Allergy and Clinical Immunology. All rights reserved.
Keywords
- Disease management
- Guideline
- Therapeutics
- Urticaria